Fear is the worst thing against you,” said William Brtis, who was diagnosed with two different cancers six days apart.

Innovent Biologics, Inc. ('Innovent') (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, ...

In the last year, some drugmakers have pulled back from the sector, including Pfizer, which recently stopped selling its gene ...

Mount Sinai scientists will continue studying PGV001 in larger groups of patients and testing how it works with other cancer treatments. Data from this phase 1 study have prompted three additional ...

Toon Van Gorp, MD, PhD, discussed findings from the MIRASOL trial and the potential of mirvetuximab to redefine treatment ...

As a breast cancer survivor, I feel it is incumbent upon me to give an accurate picture of cancer to others, particularly ...

Sarah Ferguson presents Australia's premier daily current affairs program, delivering agenda-setting public affairs ...

First patient dosed in Phase II OCULE-01 study with roginolisib, an allosteric modulator of PI3KdThe European Medicines Agency (EMA) has granted Orphan Drug Designation for roginolisib for treatment ...

One of two of Opthea's phase III trials for a common eye disease has failed to meet its primary endpoints, ... Read More The ...

Ward Cheskey follows up routinely with his oncologist, Heidi McKean after being diagnosed with rectal cancer in 2023.

India's healthcare system is plagued by a profit-driven model that disproportionately benefits hospital owners, leaving ...

A 32-year-old non-smoking woman experienced sudden blindness in one eye, which led to the discovery of metastatic lung cancer that had spread to her eyes and multiple organs.